Sunshine Biopharma Inc (SBFM): Next-Year EPS Estimate 103.17%
As of 2026-06-04, Sunshine Biopharma Inc (SBFM) has a next-year EPS growth estimate of 103.17%.
On 2026-05-18, analyst consensus for SBFM's next-year EPS growth shifted from 105.00% to 103.17% — a negative change of 1.83 percentage points. The revised estimate has been sustained across 14 subsequent trading sessions. Current-year growth is projected at 56.25%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 103.17%
- EPS growth this year
- 56.25%
- EPS next quarter (est)
- -$1.20
- Last price
- $2.57
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 103.17% | 56.25% | -$1.20 | $2.57 |
| 2026-06-03 | 103.17% | 56.25% | -$1.20 | $2.66 |
| 2026-06-02 | 103.17% | 56.25% | -$1.20 | $2.60 |
| 2026-06-01 | 103.17% | 56.25% | -$1.20 | $2.39 |
| 2026-05-31 | 103.17% | 56.25% | -$0.12 | $0.25 |
| 2026-05-28 | 103.17% | 56.25% | -$0.12 | $0.32 |
| 2026-05-27 | 103.17% | 56.25% | -$0.12 | $0.42 |
| 2026-05-26 | 103.17% | 56.25% | -$0.12 | $0.42 |
| 2026-05-25 | 103.17% | 56.25% | -$0.12 | $0.48 |
| 2026-05-24 | 103.17% | 56.25% | -$0.12 | $0.48 |
| 2026-05-21 | 103.17% | 56.25% | -$0.12 | $0.52 |
| 2026-05-20 | 103.17% | 56.25% | -$0.12 | $0.37 |
| 2026-05-19 | 103.17% | 56.25% | -$0.12 | $0.44 |
| 2026-05-18 | 103.17% | 56.25% | -$0.25 | $0.51 |
| 2026-05-17 | 105.00% | 72.22% | -$0.16 | $0.28 |
| 2026-05-14 | 105.00% | 72.22% | -$0.16 | $0.47 |
| 2026-05-13 | 105.00% | 72.22% | -$0.16 | $0.84 |
| 2026-05-12 | 105.00% | 72.22% | -$0.16 | $1.05 |
| 2026-05-11 | 105.00% | 72.22% | -$0.16 | $1.03 |
| 2026-05-10 | 105.00% | 72.22% | -$0.16 | $1.05 |
| 2026-05-07 | 105.00% | 72.22% | -$0.16 | $1.08 |
| 2026-05-06 | 105.00% | 72.22% | -$0.16 | $1.08 |
| 2026-05-05 | 105.00% | 72.22% | -$0.16 | $1.05 |
| 2026-05-04 | 105.00% | 72.22% | -$0.16 | $1.10 |
| 2026-05-03 | 105.00% | 72.22% | -$0.16 | $1.05 |
| 2026-04-30 | 105.00% | 72.22% | -$0.16 | $0.96 |
| 2026-04-29 | 105.00% | 72.22% | -$0.16 | $0.97 |
| 2026-04-28 | 105.00% | 72.22% | -$0.16 | $0.98 |
| 2026-04-27 | 105.00% | 72.22% | -$0.16 | $0.98 |
| 2026-04-26 | 105.00% | 72.22% | -$0.16 | $1.00 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Sunshine Biopharma Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Sunshine Biopharma Inc (SBFM) has a next-year EPS growth estimate of 103.17%, based on analyst consensus.
When was the latest EPS estimate revision for SBFM?▾
The most recent revision occurred on 2026-05-18, when analysts adjusted the next-year EPS growth estimate from 105.00% to 103.17%.
What sector and industry does Sunshine Biopharma Inc belong to?▾
Sunshine Biopharma Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SBFM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Sunshine Biopharma Inc (SBFM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports